Roche Flu/Covid Test Has Potential for False Positives: FDA

March 12, 2021, 4:33 PM UTC

A Roche Molecular Systems test for flu and Covid-19 has the potential for false positive results, according to an alert from the U.S. Food and Drug Administration.

  • The co.’s cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System could produce erroneous results due to sporadic leaking of the assay tubes and abnormal PCR cycling in the reaction tubes

Link to statement

To contact the reporter on this story:
Greg Chang in San Francisco at gchang1@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2021 Bloomberg L.P. All rights reserved. ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.